Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Hers vs Revel Health

Hers and Revel Health both sell semaglutide and tirzepatide; this is how their prices, coverage and records differ.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed (not clinically reviewed). Not medical advice · How we verify contentLast reviewed
Hers logo

Hers

6.6
★★★☆☆3.3/5

Best for: coverage in all 50 states, which most sellers will not confirm

Visit Hers →
VS
Revel Health logo

Revel Health

7.6
★★★★☆3.8/5

Best for: compounded semaglutide at $199/month

Visit Revel Health →

If you are choosing between Hers and Revel Health, price alone will not settle it. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Revel Health leads our six-part score, 7.6 to 6.6. One of the two has an FDA warning letter on record, covered below.

Hers vs Revel Health price

Hers and Revel Health start at the same figure, $199 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.

Drug by drug: Semaglutide costs the same at both, $199 a month; tirzepatide is cheaper at Revel Health ($249 a month vs $299 a month).

Medications and formats

Both sell semaglutide and tirzepatide.

On format, Hers prices compounded injections and brand-name pens, while Revel Health prices compounded injections.

If you want the FDA-approved brand rather than a compounded version, Hers is the only one of the two with a brand-name price.

Where each one treats patients

Hers lists 50 states, and Revel Health lists 45 states.

They overlap in 45 states. Hers alone covers Alaska, Arkansas, Mississippi, North Carolina and New Jersey.

Pricing

Hers

StartingCompounded
$199/mo
semaglutide
StartingBrand-name
$299/mo
tirzepatide

Brand Zepbound from $299/mo medication-only; requires Hers Weight Loss Membership ($149/mo)

Revel Health

Compounded program (preliminary)compounded injection
$199/mo
semaglutide

Preliminary placeholder — Revel doesn't show upfront pricing; confirm at checkout

StartingCompounded
$249/mo
tirzepatide

Tirzepatide injection from $249/mo (first month $149)

What each price covers

Both prices cover the medication itself.

Revel Health's price also covers the clinician visit and shipping, which Hers does not claim.

Hers is silent on shipping and lab work.

Revel Health is silent on lab work and coaching.

Hers

Covered by the monthly price

Medication

In the price

Clinician visits

Charged on top

Shipping

Not stated

Lab work

Not stated

Coaching

Charged on top

Revel Health

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

Where each one scores higher

Overall, Revel Health scores 7.6 and Hers 6.6 out of 10.

Hers is stronger on accessibility (10.0 vs 9.2).

Revel Health is stronger on value (4.5 vs 3.0), trust & safety (7.5 vs 5.5) and support (7.0 vs 3.0).

Effectiveness and user experience are within half a point.

How we score

Hers

6.6/10

Overall

Revel Health

7.6/10

Value25%

3.0A
vs
B
4.5

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

5.5A
vs
B
7.5

Accessibility10%

10.0A
vs
B
9.2

Support10%

3.0A
vs
B
7.0

FDA warning letters

The FDA sent Hers a warning letter dated September 9, 2025 (letter 716825), and it is still open.

Revel Health has no FDA warning letter on record with us.

Features & Coverage

FeatureHersRevel Health
Starting Price$199/mo$199/mo
Features2 features✓8 features
States Available✓5045
Compounded✓ Yes✓ Yes
Brand Name✓ Yes—
FSA/HSA Accepted——
FDA Warning Letters1 letter✓None

About Hers

Hers is the women-focused telehealth brand from Hims and Hers. It sells compounded semaglutide on a 6-month plan.

Read our full Hers review →

About Revel Health

Revel Health keeps its prices off the front of the funnel. Turnaround on the intake is quick: a physician reads it inside an hour, then medication goes out. Board-certified physicians write the GLP-1s, semaglutide and tirzepatide, compounded at facilities meeting USP 795/800, and the same platform sells NAD+, sermorelin and peptide therapy on a longevity angle. It carries LegitScript certification and reaches 45 states; Alaska, Arkansas, North Carolina, New Jersey and Mississippi are out.

Read our full Revel Health review →

Pros & Cons

Hers

What we like

  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes the medication
  • Serves all 50 states

Watch-outs

  • Not included in the monthly price: clinician visits, coaching
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • The FDA has issued Hers a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
  • Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality

Revel Health

What we like

  • Semaglutide costs $199 a month, close to the $185 median for compounded semaglutide across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes the medication, clinician visits and shipping
  • Serves 45 states
  • We found no FDA warning letters issued to Revel Health

Watch-outs

  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: Revel Health

Revel Health wins this one, 7.6 to 6.6, above all for compounded semaglutide at $199/month. Hers fits better if coverage in all 50 states, which most sellers will not confirm is your priority.

Choose Hers if…

You want coverage in all 50 states, which most sellers will not confirm and an opening price near $199 a month.

Choose Revel Health if…

You want compounded semaglutide at $199/month and an opening price near $199 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

6.6

Luvo Health

Moving between compounded and brand without changing seller

8.4

Strut Health

Semaglutide at $99/month, 48% below the typical price

8.4

Enhance MD

Knowing which pharmacy fills the vial: it names Tru Meds Rx

Hers vs Revel Health: FAQ

Neither on the entry price: Hers and Revel Health both start at about $199 a month. The difference is in what the price includes.
Yes, both sell semaglutide and tirzepatide.
Hers: 50 states against 45, with 45 in common.
Both include the medication itself. Only Revel Health includes the clinician visit and shipping.
Hers has an open FDA warning letter from September 9, 2025. Revel Health has none.
No. Neither Hers nor Revel Health pays us anything.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.